id: https://w3id.org/pcdc/model 
title: LinkML Data Dictionary model
name: data-dictionary
license: https://creativecommons.org/licenses/by-nc/4.0/
version: 0.0.1

prefixes:
 linkml: https://w3id.org/linkml/
 schema: https://schema.org/
 ex: https://example.org/linkml/hello-world/ 
 ncit: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=

# default_prefix: ex 
default_curi_maps:
 - semweb_context
default_range: string

imports:
 - linkml:types

classes:
  NamedThing:
    abstract: true
    slots:
      - submitter_id
      - type
  Person:
    is_a: NamedThing
    description: demographic information about an individual
    class_uri: schema:Person # see if we actually need this/ how this is used
    slots:
      - sex
      - race
      - race_other
      - ethnicity
      # https://portal.pedscommons.org/DD?view=table shows we also have a projects attribute 
  FamilyMedicalHistory:
    is_a: NamedThing
    description: prior cancer information of a first-degree relative
    class_uri: schema:FamilyMedicalHistory
    slots:
      - prior_cancer
      - relation
      - prior_cancer_type
      - subjects 
  Subject:
    is_a: NamedThing
    description:
    class_uri: schema:Subject
    slots:
      - honest_broker_subject_id
      - consortium
      - data_contributor_id
      - study_id
      - age_at_enrollment
      - year_at_enrollment
      - treatment_arm
      - enrolled_status
      - efs_censor_status
      - age_at_censor_status
      - data_source
      - randomized_status
      - study_phase
      - study_type
    attributes:
      persons: # not setting multivalued = true because subject cannot have multiple persons but person can be multiple subjects
        range: Person
  Timing: # NOTE: at some point we want to create a parent class that Disease Phase Timing and Course Timing classes inherit from so that we don't have to lump this all together
    is_a: NamedThing
    description: 
    class_uri: schema:Timing
    slots:
      - age_at_course_anc_500
      - age_at_course_end
      - age_at_course_start
      - age_at_cyle_end
      - age_at_cycle_start
      - age_at_disease_phase
      - age_at_txassign
      - course
      - course_number
      - cycle_number
      - disease_phase
      - disease_phase_number
      - timing_type
      - timings
      - year_at_disease_phase
      - subjects

slots:
  # NamedThing
  submitter_id:
    description: PCDC internal event ID
  type:
    description: Default system-assigned property for each node
  # Demographic Slots
  sex:
    description: The biological sex of the subject.
    range: SexEnum
    required: True
  race:
    description: A group of people who share physical characteristics, such as skin color and facial features. They may also share similar social or cultural identities and ancestral backgrounds. There are many racial groups, and a person may belong to or identify with more than one group. Some diseases, such as cancer, may be more common in certain races than in others. (Source NCI Dictionary of Cancer Terms)
    range: RaceEnum
    required: True
  race_other: # string default
    description: Specify the "Other" RACE
  ethnicity:
    description: The social and cultural characteristics, backgrounds, or experiences shared by a group of people. These include language, religion, beliefs, values, and behaviors that are often handed down from one generation to the next. Some conditions or diseases, such as cancer, may be more common in certain ethnic groups than in others. (Source NCI Dictionary of Cancer Terms)
    range: EthnicityEnum
    required: True
  # Family History Slots
  prior_cancer: # do I need to add the Variable Code ncit (meaning in enums) somewhere for these (ex. ncit:C17726)
    description: Does the subject have a relative who has a medical history that includes cancer?
    range: YesNoUnknownNotReportedEnum
    required: True
  relation:
    description: What kind of relation is this relative who has had a relevant medical condition?
    range: RelationEnum
  prior_cancer_type: # string default
    description: The type of prior cancer from the medical history of the relative of the subject.
  subjects: # list of subject objects
    multivalued: True
    range: Subject
  # Subject Slots
  honest_broker_subject_id:
    description: The identifier assigned to the subject by the honest broker--an individual, organization or system acting for, or on behalf of, a covered entity to collect and provide health information to research investigators in such a manner whereby it would not be reasonably possible for the investigators or others to identify the corresponding patients-subjects directly or indirectly. The honest broker cannot be one of the investigators. The information provided to the investigators by the honest broker may incorporate linkage codes to permit information collation and/or subsequent inquiries (i.e., a "re-identification code"), however the information linking this re-identification code to the patient's identity must be retained by the honest broker and subsequent inquiries are conducted through the honest broker. (Source NCI Thersaurus)
    identifier: True
  consortium:
    description: The consortium under which this data is being contributed to the Pediatric Cancer Data Commons.
    range: ConsortiumEnum
  data_contributor_id: # is there a combination of the ids that makes a unique entry (i.e honest_broker + data_contributor...) or is it just the honest broker 
    description: An identifier assigned to a data contributor.
    range: DataContributorIdEnum
  study_id: 
    description: A sequence of characters used to identify, name, or characterize the study.
    range: StudyIdEnum
  age_at_enrollment:
    description: Age of subject (in days) when the subject enrolled in the study.
    range: integer
  year_at_enrollment:
    description: The year at which a subject enrolled in a study.
    range: integer
  treatment_arm:
    description: A specific treatment plan within a clinical trial that describes the activities a subject will be involved in as he or she progresses through the study.
    range: TreatmentArmEnum
  enrolled_status: 
    description: This variable indicates if the subject was enrolled in the study, or if the subject was not enrolled in the study but received treatment per the study's protocol.
    range: EnrolledStatusEnum
  efs_censor_status:
    description: The event free survival censor status
    range: CensorStatusEnum
  age_at_censor_status:
    description: Age (in days) of the subject at the time of the CENSOR_STATUS
    range: integer
  data_source:
    description: The nature of the investigation or the investigational use for which clinical study is being done.
    range: DataSourceEnum
  randomized_status:
    description: The allocation of individuals to groups by chance, especially in order to control the variables in an experiment.
    range: RandomizedStatusEnum
  study_phase:
    description: The phase of the clinical trial that the subject was enrolled in for the collection of this data.
    range: StudyPhaseEnum
  study_type:
    description: The nature of the investigation or the investigational use for which clinical study is being done.
    range: StudyTypeEnum
  # Timing Slots
  age_at_course_anc_500:
    description: Age in Days When Neutrophil Count Exceeded 500 (ANC/mm3)
    range: integer
  age_at_course_end:
    description: Age of subject (in days) at the end of the course.
    range: integer
  age_at_course_start:
    description: Age of subject (in days) at the start of the course.
    range: integer
  age_at_cyle_end:
    description: Age in Days at Cycle End
    range: integer
  age_at_cycle_start:
    description: Age in Days at Cycle Start
    range: integer
  age_at_disease_phase:
    description: Age of subject (in days) at the disease phase.
    range: integer
  age_at_txassign:
    description: Age in Days at Treatment Assignment.
    range: integer
  course: 
    description: The type of protocol treatment course administered.
    range: CourseEnum
  course_number:
    description: The number assigned to a course of therapeutic agent administration, indicating where a particular course of treatment falls within a sequence of treatments.
    range: integer
  cycle_number:
    description: Cycle Number
    range: integer
  disease_phase: 
    description: The phase of the cancer treatment process during which relevant observations were recorded. This variable is used across domains to frame the timing of these longitudinal observations and reduce the number of redundant variables needed to report similar concepts (see "Disease Phase Timing and Course Table" in the documentation for additional guidance).
    range: DiseasePhaseEnum
  disease_phase_number:
    description: The number of the disease phase.
    range: integer # shouldn't there be a permissible set of numbers corresponding to the number of disease phases?
  timing_type:
    description: The time frame or phase the patient got a treatment or data have been collected
    any_of: # can either be a course or a disease phase
      - range: CourseEnum
      - range: DiseasePhaseEnum
  timings:
    description: 
    range: Timing # can reference a parent of the same type
  year_at_disease_phase: 
    description: Year of disease phase
    range: integer

enums:
  SexEnum:
    permissible_values:
      "Male":
        description: A person who belongs to the sex that normally produces sperm. The term is used to indicate biological sex distinctions, cultural gender role distinctions, or both.
        meaning: ncit:C20197
      "Female":
        description: A person who belongs to the sex that normally produces ova. The term is used to indicate biological sex distinctions, or cultural gender role distinctions, or both.
        meaning: ncit:C16576
      "Undifferentiated":
        description: Sex could not be determined; not uniquely defined; undifferentiated.
        meaning: ncit:C41438 
      "Unknown":
        description: Reported as unknown by the data contributor.
        meaning: ncit:C17998
      "Not Reported":
        description: Not provided or available.
        meaning: ncit:C43234
  RaceEnum:
    permissible_values:
      "American Indian or Alaska Native":
        description: A person having origins in any of the original peoples of North and South America (including Central America) and who maintains tribal affiliation or community attachment. (OMB)
        meaning: ncit:C41259
      "Asian":
        description: A person having origins in any of the original peoples of the Far East, Southeast Asia, or the Indian subcontinent, including for example, Cambodia, China, India, Japan, Korea, Malaysia, Pakistan, the Philippine Islands, Thailand, and Vietnam. (OMB)
        meaning: ncit:C41260
      "Black or African American":
        description: A person having origins in any of the Black racial groups of Africa. Terms such as "Haitian" or "Negro" can be used in addition to "Black or African American". (OMB)
        meaning: ncit:C16352
      "Multiracial":
        description: Having ancestors of several or various races.
        meaning: ncit:C67109
      "Native Hawaiian or Other Pacific Islander":
        description: A person having origins in any of the original peoples of Hawaii, Guam, Samoa, or other Pacific Islands. (OMB)
        meaning: ncit:C41219
      "White":
        description: A person having origins in any of the original peoples of Europe, the Middle East, or North Africa. (OMB)
        meaning: ncit:C41261
      "Other":
        description: Different than the one(s) previously specified or mentioned.
        meaning: ncit:C17649
      "Unknown":
        description: Reported as unknown by the data contributor.
        meaning: ncit:C17998
      "Not Reported":
        description: Not provided or available.
        meaning: ncit:C43234
  EthnicityEnum:
    permissible_values:
      "Hispanic or Latino":
        description: A person of Cuban, Mexican, Puerto Rican, South or Central American, or other Spanish culture or origin, regardless of race. The term, "Spanish origin," can be used in addition to "Hispanic or Latino." (OMB)
        meaning: ncit:C17459
      "Not Hispanic or Latino":
        description: A person not of Cuban, Mexican, Puerto Rican, South or Central American, or other Spanish culture or origin, regardless of race.
        meaning: ncit:C41222
      "Unknown":
        description: Reported as unknown by the data contributor.
        meaning: ncit:C17998
      "Not Reported": 
        description: Not provided or available.
        meaning: ncit:C43234
  YesNoUnknownNotReportedEnum:
    permissible_values:
      "Yes":
        description: The affirmative response to a question.
        meaning: ncit:C49488
      "No":
        description: The non-affirmative response to a question.
        meaning: ncit:C49487
      "Unknown":
        description: Reported as unknown by the data contributor.
        meaning: ncit:C17998
      "Not Reported":
        description: Not provided or available.
        meaning: ncit:C43234
  RelationEnum:
    permissible_values:
      "Father":
        description: A male who contributes to the genetic makeup of his offspring through the fertilization of an ovum by his sperm.
        meaning: ncit:C96572
      "Mother":
        description: A female who contributes to the genetic makeup of her offspring from the fertilization of her ovum.
        meaning: ncit:C96580
      "Brother":
        description: A male who shares with his sibling the genetic makeup inherited from one or both of their shared biological parents.
        meaning: ncit:C96570
      "Sister":
        description: A female who shares with her sibling the genetic makeup inherited from one or both of their shared biological parents.
        meaning: ncit:C96586
      "Son":
        description: A male progeny with genetic makeup inherited from the parent.
        meaning: ncit:C150888
      "Daughter":
        description: A female progeny with genetic makeup inherited from the parent.
        meaning: ncit:C150887
  ConsortiumEnum:
    permissible_values:
      "INSTRuCT":
        description: International Soft Tissue Sarcoma Consortium (INSTRuCT)
      "MaGIC":
        description: Malignant Germ Cell International Consortium (MaGIC)
      "INRG":
        description: International Neuroblastoma Risk Group (INRG)
      "NODAL":
        description: Hodgkin Lymphoma Data Collaboration (NODAL)
      "INTERACT":
        description: International Pediatric Acute Myeloid Leukemia Consortium (INTERACT)
      "HIBiSCus":
        description: Harmonization International Bone Sarcoma Consortium (HIBiSCus)
      "INSPiRE":
        description: International Central Nervous System Pediatric Research Consortium (INSPiRE)
      "Global REACH":
        description: Global Retinoblastoma Alliance for Children (Global REACH)
      "C3P":
        description: Consortium for Childhood Cancer Predisposition (C3P)
  DataContributorIdEnum:
    permissible_values:
      "AIEOP":
        description: Italian Association of Pediatric Hematology and Oncology is a group from Bologna, Italy, comprised mainly of pediatricians, hematologists, oncologists, surgeons, biologists, nurses and psychologists who are devoted to addressing the problems of hematology, oncology and immunology in the child and adolescent.
        meaning: ncit:C168887
      "BFM-SG":
        description: A study group formed in 1975 by three individuals, Hansjorg Riehm in Berlin (B), Bernhard Kornhuber in Frankfurt (F) and Gunther Schellong in Munster (M), who initiated the first multicenter BFM trial. The BFM treatment concept was based on an intensive chemotherapeutic approach employing eight different drugs which led to a revolutionary increase in the survival of children and adolescents with acute lymphoblastic leukemia.
        meaning: ncit:C168888
      "COG":
        description: Children's Oncology Group. An NCI-supported clinical cooperative group formed by the merger of the four national pediatric cancer research organizations (the Children's Cancer Group, the Intergroup Rhabdomyosarcoma Study Group, the National Wilms Tumor Study Group, and the Pediatric Oncology Group. The primary objective of the organization is to conduct clinical trials of new therapies for childhood and adolescent cancer. COG develops and coordinates clinical trials conducted at the 238 member institutions that include cancer centers of all major universities and teaching hospitals throughout the U.S. and Canada, as well as sites in Europe and Australia. COG members include over 5000 cancer researchers.)
        meaning: ncit:C39353
      "DCOG":
        description: A collaborating partner in Innovative Therapies for Children with Cancer Consortium (ITCC), a European based consortium to promote the clinical evaluation of new anti-cancer compounds in children with cancer.
        meaning: ncit:C168889
      "MRC":
        description: Medical Research Council. A publicly funded organization that is part of United Kingdom Research and Innovation, and is dedicated to improving human health through world-class medical research.
        meaning: ncit:C168892
  StudyIdEnum:
    permissible_values:
      "AAML03P1":
        description: # no description
        meaning: ncit:C168936
      "AAML0531":
        description: # no description
        meaning: ncit:C168937
      "AAML1031":
        description: # no description
        meaning: ncit:C168938
      "AMLBFM2004":
        description: # no description
        meaning: ncit:C168939
      "AMLBFM2012":
        description: # no description
        meaning: ncit:C173250
  TreatmentArmEnum:
    permissible_values:
      "MAP-GR":
        description: A control arm for patients receiving a regimen of methotrexate, doxorubicin and cisplatin (MAP) after good response to the MAP regimen pre-operatively.
        meaning: ncit:C186769
      "MAP-IFN-GR":
        description: An experimental treatment arm for patients receiving a regimen of methotrexate, doxorubicin and cisplatin (MAP) plus interferon (IFN) post-operatively after good response to the MAP regimen pre-operatively.
        meaning: ncit:C186770
      "MAP-PR":
        description: A control arm for patients receiving a regimen of methotrexate, doxorubicin and cisplatin (MAP) after poor response to the MAP regimen pre-operatively.
        meaning: ncit:C186771
      "MAP-IE-PR":
        description: An experimental treatment arm for patients receiving a regimen of methotrexate, doxorubicin and cisplatin (MAP) plus a regimen of ifosfamide and etoposide (IE) post-operatively after poor response to the MAP regimen pre-operatively.
        meaning: ncit:C186772
      "MAP-NR":
        description: A control arm for patients receiving a regimen of methotrexate, doxorubicin and cisplatin (MAP) with no response.
        meaning: ncit:C186773
  EnrolledStatusEnum:
    permissible_values:
      "Enrolled":
        description: The study subject is enrolled.
        meaning: ncit:C142715
      "Not Enrolled":
        description: The study subject is not enrolled.
        meaning: ncit:C168929
      "Unknown":
        description: Reported as unknown by the data contributor.
        meaning: ncit:C17998
      "Not Reported":
        description: Not provided or available.
        meaning: ncit:C43234
  CensorStatusEnum:
    permissible_values:
      "Censored":
        description: Subject is censored (i.e. has had no events(s))
      "Not Censored":
        description: Subject has had one or more events
      "Unknown":
        description: Reported as unknown by the data contributor.
        meaning: ncit:C17998
      "Not Reported":
        description: Not provided or available.
        meaning: ncit:C43234
  DataSourceEnum:
    permissible_values:
      "Registry":
        description: Cancer registries gather a wide variety of specific information on cancer patients that can be analyzed to identify health disparity trends in cancer incidence, mortality and patient survival.
        meaning: ncit:C15753
      "Therapeutic Trial":
        description: A clinical study that involves administering of exposure to the agent/agents to subjects with particular disease to elucidate the most appropriate treatment for a specific medical condition, or to prolong or improve the patient's life.
        meaning: ncit:C39536
      "Unknown":
        description: Reported as unknown by the data contributor.
        meaning: ncit:C17998
      "Not Reported":
        description: Not provided or available.
        meaning: ncit:C43234
  RandomizedStatusEnum:
    permissible_values:
      "Randomized":
        description: Assignment of subjects by chance to groups that receive different treatments.
        meaning: ncit:C15417
      "Non-Randomized": 
        description: A clinical trial in which participants may choose or be assigned into groups by researchers. Their assignment is not random.
        meaning: ncit:C93043
      "Unknown":
        description: Reported as unknown by the data contributor.
        meaning: ncit:C17998
      "Not Reported":
        description: Not provided or available.
        meaning: ncit:C43234
  StudyPhaseEnum:
    permissible_values:
      "Pilot":
        description: The initial study examining a new method or treatment.
        meaning: ncit:C15303
      "Phase 1":
        description: A clinical research protocol designed to test a new biomedical intervention in a small group of people for the first time. A Phase I trial can be to establish the toxicity of a new treatment with escalating intensity of the treatment administered and/or to determine the side effects of a new treatment for a particular indication in subjects.
        meaning: ncit:C15600
      "Phase 2":
        description: A clinical research protocol designed to study a biomedical or behavioral intervention in a larger group of people (several hundred), to evaluate the drug's effectiveness for a particular indication in patients with the disease or condition under study, and to determine the common short-term side effects and risks associated with the intervention.
        meaning: ncit:C15601
      "Phase 3":
        description: A clinical research protocol designed to investigate the efficacy of the biomedical or behavioral intervention in large groups of human subjects (from several hundred to several thousand), to confirm efficacy, to monitor adverse reactions to the new medication or treatment regimen with respect to long-term use and by comparing the intervention to other standard or experimental interventions as well as to a placebo.
        meaning: ncit:C15602
      "Unknown":
        description: Reported as unknown by the data contributor.
        meaning: ncit:C17998
      "Not Reported":
        description: Not provided or available.
        meaning: ncit:C43234
  StudyTypeEnum:
    permissible_values:
      "Frontline":
        description: A clinical trial for previously untreated patients that studies the use of a first line of treatment.
        meaning: ncit:C185306
      "Retrieval":
        description: A trial to assess the efficacy of reinduction therapy.
        meaning: ncit:C185307
      "Unknown":
        description: Reported as unknown by the data contributor.
        meaning: ncit:C17998
      "Not Reported":
        description: Not provided or available.
        meaning: ncit:C43234
  CourseEnum:
    permissible_values:
      "Neo-Adjuvant":
        description: Therapy administered prior to the initial therapy.
        meaning: ncit:C158708
      "Prephase":
        description: A chemotherapy treatment administered prior to the definitive chemotherapy treatment.
        meaning: ncit:C168826
      "Induction":
        description: The first choice of treatment for a particular type of cancer.
        meaning: ncit:C158876
      "Bridge/Preconsolidation":
        description: # no data
        meaning: # no data
      "Maintenance":
        description: Continuation of treatment for an extended period of time to prevent relapse.
        meaning: ncit:C15688
      "Consolidation":
        description: Treatment that is given after initial therapy to kill any remaining cancer cells.
        meaning: ncit:C15679
      "Intensification":
        description: A second round of intense chemotherapy as part of consolidation therapy.
        meaning: ncit:C173105
      "Delayed Intensification":
        description: A repeat of the first two months of induction and consolidation chemotherapy in high-risk and very-high-risk ALL protocols with the goal of eliminating residual drug-resistant cells
        meaning: ncit:C178270
      "Interim Maintenance":
        description: A less intense phase of chemotherapy in between each course of delayed intensification.
        meaning: ncit:C178069
      "Adjuvant":
        description: Chemotherapy that is administered subsequent to the main treatment plan to minimize or prevent disease recurrence.
        meaning: ncit:C15360
      "Post-Consolidation":
        description: # no data 
        meaning: # no data
      "Continuation":
        description: A period in a clinical study during which subjects receive continuation therapy. This therapy is usually different from the therapy given during the induction phase and administered over a longer period of time.
        meaning: ncit:C123452
      "Palliative Treatment":
        description: The patient- and family-centered active holistic care of patients with advanced, progressive disease. Essential components of Palliative Care are:pain and symptom control, communication regarding treatment and alternatives, prognosis, and available services, rehabilitation services, care that addresses treatment and palliative concerns, intellectual, emotional, social, and spiritual needs, terminal care, support in bereavement. The goal of Palliative Care is an achievement of the best quality of life for patients and their families.
        meaning: ncit:C15292
      "Chemotherapy Window":
        description: # no data
        meaning: # no data
      "Stem Cell Transplant Conditioning":
        description: A regimen that can be used as a conditioning regimen for hematopoietic stem cell transplantation (HSCT).
        meaning: ncit:C168794
      # from here down were in red in the spreadsheet so I am not sure if  that means that they should not be included
      "Chemotherapy": 
        description: The use of synthetic or naturally-occurring chemicals for the treatment of diseases.
        meaning: ncit:C15632
      "Chemotherapy Alone":
        description: The use of synthetic or naturally-occurring chemicals for the treatment of diseases.
        meaning: ncit:C15632
      "Investigational Agent": 
        description: A new drug or biological drug that is used in a clinical investigation. The term also includes a biological product that is used in vitro for diagnostic purposes.
        meaning: ncit:C49135
      "Radiation Therapy":
        description: Treatment of a disease by means of exposure of the target or the whole body to radiation. Radiation therapy is often used as part of curative therapy and occasionally as a component of palliative treatment for cancer. Other uses include total body irradiation prior to transplantation.
        meaning: ncit:C15313
      "Chemoimmunotherapy":
        description: Chemotherapy combined with immunotherapy. Chemotherapy uses different drugs to kill or slow the growth of cancer cells; immunotherapy uses treatments to stimulate or restore the ability of the immune system to fight cancer.
        meaning: ncit:C94251
      "Immunotherapy":
        description: Therapy designed to induce changes in a patient's immune status in order to treat disease.
        meaning: ncit:C15262
      # also these don't exactly match https://portal.pedscommons.org/DD?view=table, should there be an OTHER option?
  DiseasePhaseEnum:
    permissible_values:
      "Initial Diagnosis":
        description: The first diagnosis of the individual's condition.
        meaning: ncit:C156813
      "Relapse":
        description: The return of a disease after a period of remission.
        meaning: ncit:C38155
      "Progression":
        description: The worsening of a disease over time.
        meaning: ncit:C17747
      "Relapse/Progression":
        description: Either the return of the disease or the progression of the disease.
        meaning: ncit:C174991
      "Refractory":
        description: Not responding to treatment.
        meaning: ncit:C38014

    
